A new generation of therapeutics
Explore. Discover. Innovate. Cure.
What we do
MyNeuroCure is a biotechnology company dedicated to exploring novel treatment solutions to treat neurological diseases that currently have a limited selection of effective treatment options.
​
Grounded in breakthrough scientific innovation, we are currently exploring the potential of a novel MANF fragment as an innovative treatment for ALS, with the goal of bringing a game-changing treatment option that finally meets the unmet needs in the therapy market.
Renowed
team of researchers
State-of-the-Art Facilities
Innovative approach
A pipeline of a
first-of-its-kind
There is a high unmet need for effective therapies for those whose lives are cut short by fatal Amyotrophic Lateral Sclerosis (ALS).
​
Current therapeutics are hindered by limited efficacy, severe toxicity, invasive and risky routes of administration, and elevated manufacturing costs. Using our discovery, we are determined to harness the potential of MANF fragments for treatment of ALS and other neurological diseases.
​​​
MNC101-ALS
